Interfering with the Drp1 upstream kinase AMPK or cyclin B1/Cdk1 via metformin or cucurbitacin E increased the chemosensitivity of NPC tumors to cisplatin. Here, CCNB1 is linked to nasopharyngeal carcinoma.